Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment With a Prospective Post-Marketing Surveillance Study

Drugs - Real World Outcomes - Switzerland
doi 10.1007/s40801-019-0150-8
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC


Related search